Susquehanna Fundamental Investments, LLC Reata Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $94,244 - $408,332	-3,680 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $725,000 - $1.04 Million	-7,250 Reduced 66.33%	3,680 $370,000
Q2 2021 Aug 11, 2021	BUY	$78.27 - $151.29 $855,491 - $1.65 Million	10,930 New	10,930 $1.55 Million
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $2.58 Million - $3.63 Million	-27,340 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $1.79 Million - $3.24 Million	17,540 Added 178.98%	27,340 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $159,001 - $277,678	1,700 Added 20.99%	9,800 $955,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.02 Million - $1.43 Million	8,100 New	8,100 $1.26 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.